These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17563730)

  • 21. Haptoglobin polymorphism and diabetic retinopathy in Brazilian patients.
    Wobeto VP; Rosim ET; Melo MB; Calliari LE; Sonati Mde F
    Diabetes Res Clin Pract; 2007 Sep; 77(3):385-8. PubMed ID: 17275123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus.
    Park HK; Ahn CW; Lee GT; Kim SJ; Song YD; Lim SK; Kim KR; Huh KB; Lee HC
    Diabetes Res Clin Pract; 2002 Feb; 55(2):151-7. PubMed ID: 11796181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association study of sorbitol dehydrogenase -888G>C polymorphism with type 2 diabetic retinopathy in Caucasian-Brazilians.
    Ferreira FN; Crispim D; Canani LH; Gross JL; dos Santos KG
    Exp Eye Res; 2013 Oct; 115():140-3. PubMed ID: 23850972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decline in neurophysiological function after 7 years in an adolescent diabetic cohort and the role of aldose reductase gene polymorphisms.
    Thamotharampillai K; Chan AK; Bennetts B; Craig ME; Cusumano J; Silink M; Oates PJ; Donaghue KC
    Diabetes Care; 2006 Sep; 29(9):2053-7. PubMed ID: 16936152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in Type 2 diabetes in Caucasians.
    Petrovic MG; Peterlin B; Hawlina M; Petrovic D
    J Diabetes Complications; 2005; 19(2):70-3. PubMed ID: 15745835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A M55V polymorphism in the SUMO4 gene is associated with a reduced prevalence of diabetic retinopathy in patients with Type 1 diabetes.
    Rudofsky G; Schlotterer A; Humpert PM; Tafel J; Morcos M; Nawroth PP; Bierhaus A; Hamann A
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):14-7. PubMed ID: 17926234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldose reductase gene polymorphisms and diabetic retinopathy susceptibility.
    Abhary S; Burdon KP; Laurie KJ; Thorpe S; Landers J; Goold L; Lake S; Petrovsky N; Craig JE
    Diabetes Care; 2010 Aug; 33(8):1834-6. PubMed ID: 20424224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An aldose reductase intragenic polymorphism associated with diabetic retinopathy.
    Kao YL; Donaghue K; Chan A; Knight J; Silink M
    Diabetes Res Clin Pract; 1999 Nov; 46(2):155-60. PubMed ID: 10724095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes.
    Li H; Louey JW; Choy KW; Liu DT; Chan WM; Chan YM; Fung NS; Fan BJ; Baum L; Chan JC; Lam DS; Pang CP
    Mol Vis; 2008 Sep; 14():1698-704. PubMed ID: 18806884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
    Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The -106CC genotype of the aldose reductase gene is associated with an increased risk of proliferative diabetic retinopathy in Caucasian-Brazilians with type 2 diabetes.
    dos Santos KG; Canani LH; Gross JL; Tschiedel B; Souto KE; Roisenberg I
    Mol Genet Metab; 2006 Jul; 88(3):280-4. PubMed ID: 16545977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus.
    Yang B; Cross DF; Ollerenshaw M; Millward BA; Demaine AG
    J Diabetes Complications; 2003; 17(1):1-6. PubMed ID: 12505748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients.
    Cyganek K; Mirkiewicz-Sieradzka B; Malecki MT; Wolkow P; Skupien J; Bobrek J; Czogala M; Klupa T; Sieradzki J
    Acta Diabetol; 2006 Dec; 43(4):114-9. PubMed ID: 17211561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive effect of aldose reductase Z-4 microsatellite polymorphism and glycaemic control on cataract development in type 2 diabetes.
    Wang Y; Luk AO; Ng MC; Pang CC; Lam V; Lee SC; Lam DS; Choy KW; Ma RC; So WY; Chan JC
    J Diabetes Complications; 2014; 28(2):147-51. PubMed ID: 24360973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy.
    Mansfield MW; Stickland MH; Carter AM; Grant PJ
    Thromb Haemost; 1994 Jun; 71(6):731-6. PubMed ID: 7974340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between MTHFR gene polymorphisms, plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus.
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Chin Med J (Engl); 2003 Jan; 116(1):145-7. PubMed ID: 12667409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Polymorphism of gene encoding vascular angiotensin II receptor and microangiopathies in patients with insulin-dependent diabetes mellitus].
    Chistiakov DA; Chugunova LA; Shamkhalova MSh; Shestakova MV; Milen'kaia TM; Dedov II; Debabov VG; Nosikov VV
    Genetika; 1999 Sep; 35(9):1289-93. PubMed ID: 10576062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between the 1858T allele of the protein tyrosine phosphatase nonreceptor type 22 and type 1 diabetes in a Brazilian population.
    Chagastelles PC; Romitti M; Trein MR; Bandinelli E; Tschiedel B; Nardi NB
    Tissue Antigens; 2010 Aug; 76(2):144-8. PubMed ID: 20331840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
    Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
    Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylenetetrahydrofolate reductase and methionine synthase reductase gene polymorphisms and protection from microvascular complications in adolescents with type 1 diabetes.
    Wiltshire EJ; Mohsin F; Chan A; Donaghue KC
    Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):348-53. PubMed ID: 18774994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.